NZ755117A - Compositions and methods for modulating hbv and ttr expression - Google Patents

Compositions and methods for modulating hbv and ttr expression

Info

Publication number
NZ755117A
NZ755117A NZ755117A NZ75511714A NZ755117A NZ 755117 A NZ755117 A NZ 755117A NZ 755117 A NZ755117 A NZ 755117A NZ 75511714 A NZ75511714 A NZ 75511714A NZ 755117 A NZ755117 A NZ 755117A
Authority
NZ
New Zealand
Prior art keywords
compositions
methods
ttr expression
modulating hbv
hbv
Prior art date
Application number
NZ755117A
Inventor
Eric E Swayze
P Prakash Thazha
P Seth Punit
Original Assignee
Ionis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ionis Pharmaceuticals Inc filed Critical Ionis Pharmaceuticals Inc
Publication of NZ755117A publication Critical patent/NZ755117A/en

Links

Abstract

Disclosed is a compound comprising a modified oligonucleotide and a conjugate group, wherein the modified oligonucleotide consists of 8 to 80 linked nucleosides and has a nucleobase sequence that is least 85% complementary to SEQ ID NO: 2.
NZ755117A 2013-05-01 2014-05-01 Compositions and methods for modulating hbv and ttr expression NZ755117A (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201361818442P 2013-05-01 2013-05-01
US201361823826P 2013-05-15 2013-05-15
US201361843887P 2013-07-08 2013-07-08
US201361871673P 2013-08-29 2013-08-29
US201361880790P 2013-09-20 2013-09-20
US201461976991P 2014-04-08 2014-04-08
US201461986867P 2014-04-30 2014-04-30
NZ74252514 2014-05-01

Publications (1)

Publication Number Publication Date
NZ755117A true NZ755117A (en) 2023-07-28

Family

ID=87654782

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ755117A NZ755117A (en) 2013-05-01 2014-05-01 Compositions and methods for modulating hbv and ttr expression

Country Status (1)

Country Link
NZ (1) NZ755117A (en)

Similar Documents

Publication Publication Date Title
NZ631537A (en) Compositions and methods for modulating apolipoprotein c-iii expression
NZ630800A (en) Methods of preparing substituted nucleotide analogs
NZ630591A (en) Microrna compounds and methods for modulating mir-21 activity
NZ630596A (en) Methods for treatment of alport syndrome
SG10201804835VA (en) Substituted nucleosides, nucleotides and analogs thereof
PH12015501423A1 (en) Substituted nucleosides, nucleotides and analogs thereof
PH12015500347A1 (en) 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
TN2015000185A1 (en) 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
TN2013000485A1 (en) 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
NZ630890A (en) Microrna compounds and methods for modulating mir-122
MY186547A (en) 4?-fluoro-2?-methyl substituted nucleoside derivatives
MX2015012633A (en) Acyclic nucleoside phosphonate diesters.
NZ723229A (en) Immunogens for hiv vaccination
MY180581A (en) A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof
MX2013012233A (en) Substituted 4-aryl-n-phenyl-1,3,5-triazin-2-amines.
NZ755117A (en) Compositions and methods for modulating hbv and ttr expression
UA104102C2 (en) α-CRYSTALLINE FORM OF CARBABENZPYRIDE
PH12015502703A1 (en) Pharmaceutical compositions
IN2013MU01219A (en)
PH12015501840A1 (en) Production method of pyridazinone compounds
AR121845A2 (en) COMPOUNDS AND COMPOSITIONS FOR MODULATING THE EXPRESSION OF TAU
IN2013MU02595A (en)
IN2013MU02771A (en)
MY163245A (en) Hepatitis c virus inhibitors

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 6 YEARS UNTIL 01 MAY 2024 BY PHILLIPS ORMONDE FITZPATRICK

Effective date: 20240124